PLK2 and Parkinson disease: Insulin resistance increases the development and progression of PD via abnormal expression of α-synuclein, enhanced production of reactive oxygen species, mitochondrial dysfunction, and deregulation of the Polo-Like Kinase 2 Signaling [61].